MGTX
MeiraGTx Holdings plc

948
Mkt Cap
$610.12M
Volume
506,609.00
52W High
$9.73
52W Low
$4.55
PE Ratio
-3.59
MGTX Fundamentals
Price
$7.43
Prev Close
$7.58
Open
$7.71
50D MA
$8.28
Beta
1.29
Avg. Volume
415,607.22
EPS (Annual)
-$2.12
P/B
-15.04
Rev/Employee
$87,346.46
Loading...
Loading...
News
all
press releases
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx...
PR Newswire·3h ago
News Placeholder
More News
News Placeholder
MeiraGTx (NASDAQ:MGTX) Downgraded by Wall Street Zen to "Sell"
Wall Street Zen downgraded MeiraGTx from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·5d ago
News Placeholder
MeiraGTx (NASDAQ:MGTX) Announces Quarterly Earnings Results
MeiraGTx (NASDAQ:MGTX - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of...
MarketBeat·6d ago
News Placeholder
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates
MeiraGTx (MGTX) delivered earnings and revenue surprises of -24.00% and -89.95%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
MeiraGTx (NASDAQ:MGTX) Trading 6.6% Higher After Analyst Upgrade
MeiraGTx (NASDAQ:MGTX) Trading Up 6.6% on Analyst Upgrade...
MarketBeat·8d ago
News Placeholder
MeiraGTx Holdings PLC (NASDAQ:MGTX) Given Average Rating of "Moderate Buy" by Analysts
MeiraGTx Holdings PLC (NASDAQ:MGTX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five brokerages that are covering the company, MarketBeat.com reports. One analyst has...
MarketBeat·8d ago
News Placeholder
Piper Sandler Increases MeiraGTx (NASDAQ:MGTX) Price Target to $30.00
Piper Sandler upped their target price on MeiraGTx from $28.00 to $30.00 and gave the stock an "overweight" rating in a report on Tuesday...
MarketBeat·8d ago
News Placeholder
Chardan Capital Reaffirms Buy Rating for MeiraGTx (NASDAQ:MGTX)
Chardan Capital reiterated a "buy" rating and issued a $35.00 price objective on shares of MeiraGTx in a report on Tuesday...
MarketBeat·8d ago
News Placeholder
MeiraGTx (NASDAQ:MGTX) Sets New 12-Month High - Still a Buy?
MeiraGTx (NASDAQ:MGTX) Sets New 12-Month High - Here's Why...
MarketBeat·9d ago
News Placeholder
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle?
As part of its collaboration with Eli Lilly, MeiraGTx will grant it worldwide exclusive rights to its AAV-AIPL1 program for the treatment of Leber congenital amaurosis 4.
Stocktwits·10d ago

Latest MGTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.